Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ).
Zylox-Tonbridge Medical Technology Co., Ltd. announced the resignation of Mr. Stephen Hui Wang as a non-executive director, effective March 31, 2025, due to other work commitments. The board expressed gratitude for Mr. Wang’s contributions, and his departure is not expected to impact the company’s operations or stakeholder relations.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and providing advanced medical devices and solutions.
YTD Price Performance: 43.85%
Average Trading Volume: 141
Technical Sentiment Signal: Sell
Current Market Cap: €634.9M
For a thorough assessment of 2190 stock, go to TipRanks’ Stock Analysis page.